Emergent TV ads bookend its tumultuous year. Can military, Narcan work help rehab its brand?
When the Covid-19 pandemic hit, Emergent BioSolutions was relatively unknown. But the contract development and manufacturing organization (CDMO) suddenly hit the spotlight when it nabbed a massive $628 million government deal in mid-2020 to manufacture Johnson & Johnson and AstraZeneca Covid-19 vaccines.
Emergent saw an opportunity to introduce the public to its brand. Along with its CDMO work, Emergent makes its own vaccines and commercial meds, including the Narcan opioid reversal agent, as well as medical countermeasure products like smallpox and anthrax vaccines.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 129,700+ biopharma pros reading Endpoints daily — and it's free.